The Thursday morning news reports: January 8, 2009

This morning’s news reports address:

  • Prostate cancer risk and obesity (again)
  • Italian experience with HIFU at a median follow-up of about 2 years
  • The prognostic value of a 5-year PSA value <0.2 ng/ml in men treated with brachytherapy (with or without EBRT and/or hormones)
  • Proposed European guidelines on the need to remove the seminal vesicles during radical proostatectomy
  • Comparative quality of life in men treated with brachytherapy or EBRT
  • Data on picoplatin in treatment of HRPC READ MORE …

Positive data from Phase II trial of picoplatin

Poinard Pharamceuticals has announched positive data from an ongoing trial of the investigational drug picoplatin in combination with docetaxel and prednisone for treatment of men with metastatic hormone-refractory prostate cancer who have not previously received chemotherapy of any type. … READ MORE …